Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Nicastrin-targeting antibody for cancer and Alzheimer's disease

Nov. 7, 2007

Studies describe raltegravir resistance, pharmacokinetics, efficacy

Nov. 7, 2007

TMC-278 effects on lipids, coadministration with atorvastatin reported

Nov. 7, 2007

ENMD-1198 metabolism, pharmacokinetics studied in humans

Nov. 7, 2007

Escalating doses of CR011-vcMMAE assessed in melanoma patients

Nov. 7, 2007

Selective nAChR allosteric modulator safe and effective in improving cognition in rodents

Nov. 6, 2007

Choline derivative a potential candidate for neurodegenerative and cognition disorders

Nov. 6, 2007

Selective muscarinic agonists with potential for neurological disorders presented at SfN

Nov. 6, 2007

Toll-like receptor 3 may be involved in the pathogenesis of Alzheimer's disease

Nov. 6, 2007

Oxaliplatin formulation MBP-426 well tolerated in phase I study

Nov. 6, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...